Literature DB >> 26511945

Analysis of drug-related problems in three departments of a German University hospital.

Rebekka Lenssen1,2,3, Axel Heidenreich4, Jörg B Schulz5, Christian Trautwein6, Christina Fitzner7, Ulrich Jaehde8, Albrecht Eisert9.   

Abstract

BACKGROUND: During the last decades, pharmaceutical care services have been developed and implemented to optimize drug therapies and ensure medication safety. To investigate the need for pharmaceutical care services, drug-related problems can be measured.
OBJECTIVE: Thus, the aim of this study was to analyse number, type and occurrence of drug-related problems in different clinical departments.
SETTING: A pharmaceutical care service was established on general wards in Urology, Neurology and Gastroenterology at the University Hospital RWTH Aachen, Germany.
METHOD: For each of a total of 306 patients, a pharmacist conducted an extended medication history, performed medication reconciliation, conducted medication safety checks and if drug-related problems were discovered, gave valid recommendations to the attending healthcare team. Drug-related problems were classified using the APS-Doc system. For statistical analyses, SAS(®) 9.1.3, SAS Institute, Cary NC, USA was applied. The project was approved by the local ethics committee. MAIN OUTCOME MEASURE: Type, occurrence and frequency of DRP in different medical departments.
RESULTS: On average, 2.3 drug-related problems per patient were documented for all three departments. Drug-related problems were found in each category of the APS-Doc system. The most pronounced drug-related problems found were drug-drug interactions (34.6 %). 37 % of the identified drug-related problems occurred before hospital admission, 27 % during transitional care, and 36 % on the ward. Subgroup analysis revealed specific drug-related problem patterns for each clinical department. The number of drug-related problems was found to be associated with the number of drugs and age.
CONCLUSION: Drug-related problems frequently occur in all investigated clinical departments. A holistic pharmaceutical care service could be an option to address this issue. In case of limited resources, individual drug-related problem patterns can be used as a basis for a tailored pharmaceutical care service. As number of drugs and age have been shown to be significant risk factors, it is crucial that the healthcare team including the pharmacist pays special attention to elderly patients and those with polymedication.

Entities:  

Keywords:  Drug-related problems; Gastroenterology; Germany; Medication safety; Neurology; Pharmaceutical care; Urology; Ward-based pharmacist

Mesh:

Year:  2015        PMID: 26511945     DOI: 10.1007/s11096-015-0213-1

Source DB:  PubMed          Journal:  Int J Clin Pharm


  34 in total

Review 1.  Acceptance of pharmacists' suggestions by prescribers: a literature review.

Authors:  J D Klopfer; T R Einarson
Journal:  Hosp Pharm       Date:  1990-09

2.  Practical evaluation of the drug-related problem management process in Swiss community pharmacies.

Authors:  Jean-Marc Krähenbühl; Bertha Kremer; Bertrand Guignard; Olivier Bugnon
Journal:  Pharm World Sci       Date:  2008-04-06

Review 3.  Clinical pharmacists and inpatient medical care: a systematic review.

Authors:  Peter J Kaboli; Angela B Hoth; Brad J McClimon; Jeffrey L Schnipper
Journal:  Arch Intern Med       Date:  2006-05-08

4.  Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability.

Authors:  C Hohmann; C Eickhoff; J M Klotz; M Schulz; R Radziwill
Journal:  J Clin Pharm Ther       Date:  2011-07-26       Impact factor: 2.512

5.  Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams.

Authors:  Hege Salvesen Blix; Kirsten K Viktil; Tron Anders Moger; Asmund Reikvam
Journal:  Pharm World Sci       Date:  2006-09-27

6.  Drug-related problems in prescribed medicines in Germany at the time of dispensing.

Authors:  Andrea Nicolas; Christiane Eickhoff; Nina Griese; Martin Schulz
Journal:  Int J Clin Pharm       Date:  2013-04-20

7.  Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge.

Authors:  T Michael Farley; Constance Shelsky; Shanique Powell; Karen B Farris; Barry L Carter
Journal:  Int J Clin Pharm       Date:  2014-02-11

8.  A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial.

Authors:  Ulrika Gillespie; Anna Alassaad; Dan Henrohn; Hans Garmo; Margareta Hammarlund-Udenaes; Henrik Toss; Asa Kettis-Lindblad; Håkan Melhus; Claes Mörlin
Journal:  Arch Intern Med       Date:  2009-05-11

9.  Evaluation of a controlled, national collaboration study on a clinical pharmacy service of screening for risk medications.

Authors:  Lene Juel Kjeldsen; Marianne Hald Clemmensen; Christian Kronborg; Ulla Hedegaard; Line Hedegaard Larsen; Inger Olsen Yderstræde; Jette Lyngholm Nielsen; Trine Rune Høgh Nielsen
Journal:  Int J Clin Pharm       Date:  2013-12-18

10.  Clinical pharmacist service in the acute ward.

Authors:  Trine Rune Høgh Nielsen; Stig Ejdrup Andersen; Mette Rasmussen; Per Hartvig Honoré
Journal:  Int J Clin Pharm       Date:  2013-08-25
View more
  17 in total

Review 1.  The medication reconciliation process and classification of discrepancies: a systematic review.

Authors:  Enas Almanasreh; Rebekah Moles; Timothy F Chen
Journal:  Br J Clin Pharmacol       Date:  2016-06-29       Impact factor: 4.335

2.  Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases.

Authors:  Mostafa A Sayed Ali; Eman Mohamed Hussein Khedr; Fatma Alzahraa Hassan Ahmed; Nada Nasr Eldin Mohamed
Journal:  Int J Clin Pharm       Date:  2018-06-19

3.  Problems, interventions, and their outcomes during the routine work of hospital pharmacists in Bosnia and Herzegovina.

Authors:  Gordana Ljubojević; Branislava Miljković; Tatjana Bućma; Milica Ćulafić; Milica Prostran; Sandra Vezmar Kovačević
Journal:  Int J Clin Pharm       Date:  2017-06-09

4.  A dual intervention in geriatric patients to prevent drug-related problems and improve discharge management.

Authors:  Johanna Freyer; Lysann Kasprick; Ralf Sultzer; Susanne Schiek; Thilo Bertsche
Journal:  Int J Clin Pharm       Date:  2018-07-26

5.  The status of the performance of medication reviews in German community pharmacies and assessment of the practical performance.

Authors:  Claudia Greißing; Katharina Kössler; Johanna Freyer; Lucie Hüter; Peter Buchal; Susanne Schiek; Thilo Bertsche
Journal:  Int J Clin Pharm       Date:  2016-10-25

Review 6.  Prevalence of drug interactions in elderly patients with multimorbidity in primary care.

Authors:  Susana Sánchez-Fidalgo; Maria Isabel Guzmán-Ramos; Mercedes Galván-Banqueri; Máximo Bernabeu-Wittel; Bernardo Santos-Ramos
Journal:  Int J Clin Pharm       Date:  2017-02-25

7.  Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey.

Authors:  Nibal Abunahlah; Anfal Elawaisi; Fatih Mehmet Velibeyoglu; Mesut Sancar
Journal:  Int J Clin Pharm       Date:  2018-01-29

8.  Clinical impact of an interdisciplinary patient safety program for managing drug-related problems in a long-term care hospital.

Authors:  Oreto Ruiz-Millo; Mónica Climente-Martí; Ana María Galbis-Bernácer; José Ramón Navarro-Sanz
Journal:  Int J Clin Pharm       Date:  2017-10-19

9.  Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.

Authors:  Tâmara Natasha Gonzaga de Andrade Santos; Givalda Mendonça da Cruz Macieira; Bárbara Manuella Cardoso Sodré Alves; Thelma Onozato; Geovanna Cunha Cardoso; Mônica Thaís Ferreira Nascimento; Paulo Ricardo Saquete Martins-Filho; Divaldo Pereira de Lyra; Alfredo Dias de Oliveira Filho
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

10.  Incidence, types and acceptability of pharmaceutical interventions about drug related problems in a general hospital: an open prospective cohort.

Authors:  Valdjane Saldanha; Rand Randall Martins; Sara Iasmin Vieira Cunha Lima; Ivonete Batista de Araujo; Antonio Gouveia Oliveira
Journal:  BMJ Open       Date:  2020-04-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.